Concord Biotech Fundamentals
P/E Ratio
37.89
P/B Ratio
6.26
Div. Yield
0.95
Sector P/E
64.93
Sector P/B
3.52
Sec. Div. Yield
0.57
Concord Biotech Fundamentals is currently trading with a P/E Ratio of 37.89, compared to the sector average of 64.93. Its P/B Ratio stands at 6.26, while the sector’s is 3.52. In terms of returns, the stock offers a Dividend Yield of 0.95%, which is than the sector’s 0.57%.
Concord Biotech Score Card
Price
Expensive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Concord Biotech reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
